Ephedrine sulfate
- Product NDC
- 84549-611
- Requested package NDC
- 84549-611-25
- 11-digit product format
- 845490611
- Labeler code
- 84549
- Product ID
- 84549-611_3a38b027-e8ea-5d08-e063-6294a90a3b49
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ephedrine sulfate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- ProPharma Distribution
- Application
- ANDA216129
- Marketing category
- ANDA
- Marketing start
- 2022-04-15
- Substance
- EPHEDRINE SULFATE
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216129-001 | EPHEDRINE SULFATE | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216129-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 5c6f7cd8ea54… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216129-001 | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION / INTRAVENOUS | AP | 2022-04-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216129-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216129-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216129-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216129-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216129-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216129-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216129-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216129-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216129-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216129-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216129-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216129-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216129-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216129-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A216129-001 | AP | 1 | 5c6f7cd8ea54… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216129-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216129-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216129-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216129-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216129-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216129-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216129-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216129-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A216129-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216129-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A216129-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A216129-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A216129-001 | AP | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216129-001 | AP | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ephedrine sulfate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| EPHEDRINE SULFATE | 50 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U6X61U5ZEG | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1116294 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3843c820-f54b-5349-e063-6294a90a6b18 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1bd959e-e326-44fb-b8ca-8c56a84a2a3d | Product name | 2 | 20251211 |
| f1d178e1-1663-4c63-ae37-62a1b322fba4 | Product name | 2 | 20251106 |
| f606d3ac-dd63-4b29-bea0-db23753b8ddc | Product name | 1 | 20220118 |
| 48747306-602a-42cc-957b-5b0c69158eee | Product name | 1 | 20180604 |
| 30254138-2d98-4aa2-8e07-ae82e8b0a389 | Product name | 3 | 20171103 |
| fee762de-ffd9-404d-8bc6-8c0c208e758d | Product name | 1 | 20170426 |
| db5ebcdb-b6ae-21cd-4dc5-76cd84b5578b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-611-25 | Ephedrine sulfate | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ephedrine sulfate | EPHEDRINE SULFATE | NorthStar RxLLC | b6fc8311-7853-4666-a1c2-668a04fe2119 | 2026-06-05 | Warnings, Adverse reactions | 216129 ANDA216129 |
| Ephedrine sulfate | EPHEDRINE SULFATE | ProPharma Distribution | 3843c820-f54b-5349-e063-6294a90a6b18 | 2025-07-18 | Warnings, Adverse reactions | 216129 ANDA216129 84549-611-25 84549-611 84549061125 |
| Ephedrine sulfate | EPHEDRINE SULFATE | Medical Purchasing Solutions, LLC | 08f5ec19-7b53-681b-e063-6294a90acc86 | 2023-10-30 | Warnings, Adverse reactions | 216129 ANDA216129 |
| Ephedrine sulfate | EPHEDRINE SULFATE | Lifestar Pharma LLC | 49fc67d1-3b30-456b-951c-ca7f703432ab | 2022-04-22 | Warnings, Adverse reactions | 216129 ANDA216129 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1116294 | ePHEDrine sulfate 50 MG in 1 ML Injection | PSN | 3843c820-f54b-5349-e063-6294a90a6b18 | 3 |
| 1116294 | 1 ML ephedrine sulfate 50 MG/ML Injection | SCD | 3843c820-f54b-5349-e063-6294a90a6b18 | 3 |
| 1116294 | ephedrine sulfate 50 MG per 1 ML Injection | SY | 3843c820-f54b-5349-e063-6294a90a6b18 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84549-611-25 | 84549061125 | 1 mL in 1 VIAL, SINGLE-DOSE (84549-611-25) | 1 ml | 2025-08-27 | No | No | Current |